在美国,关于从太平洋沿岸的浆果紫杉提取抗癌药紫杉醇(taxol)的问题已引起争论,对话者反对大规模破坏紫杉树。紫杉醇正处于由国立癌症研究所发起的卵巢癌Ⅲ期临床。美国新闻界报道建议,目前的供应需增 In the United States, there has been controversy over the extraction of the taxol, an anti-cancer drug, from the Pacific Yew tree berries, and interlocutors are opposed to massive damage to yew trees. Paclitaxel is in Phase III clinical trials for ovarian cancer initiated by the National Cancer Institute. The U.S. press reported that the current supply needs to be increased